| 'Current leukemia free survival': A novel method for assessing results of allogeneic stem cell transplantation for CML that takes account of the impact of donor lymphocyte … C Pocock, C Craddock, R Szydlo, J Klein, F Dazzi, E Olavarria, ... BLOOD 94 (10), 161A-161A, 1999 | | 1999 |
| " JACIE" ACCREDITATION STATUS OF THE TRANSPLANT TEAM AND OUTCOME AFTER HEMATOPOIETIC STEM CELL TRANS-PLANTATION A Gratwohl, R Brand, E McGrath, A Van Biezen, H Baldomero, A Sureda, ... BONE MARROW TRANSPLANTATION 49, S40-S41, 2014 | | 2014 |
| “Function First” Screen of Primary AML Cells Identifies Common and Personalised Therapeutic Targets JS Khorashad, CR Fiol, E Yebra-Fernandez, E Nadal-Melsio, ... Blood 132, 1517, 2018 | | 2018 |
| “Stem cell transplantation: its importance today” Chronic myeloid leukaemia: stem cell transplantation versus new drugs J Pavlu, J Chakrabartty, JF Apperley memo-Magazine of European Medical Oncology 5 (4), 277-280, 2012 | | 2012 |
| 09. Leucémie myéloïde chronique M Mauro, Y Minami, D Rea, A Hochhaus, E Lomaia, S Voloshin, ... Hématologie 28 (1), 75-79, 2022 | | 2022 |
| 10-Year Outcome of Chronic Myeloid Leukemia Patients Resistant to Frontline Imatinib S Claudiani, AS Abulafia, I Sabli, R Szydlo, D Milojkovic, G Nesr, ... Blood 130, 1628, 2017 | | 2017 |
| 11 Bone marrow transplant for the haemoglobinopathies: past, present and future JF Apperley Baillière's clinical haematology 6 (1), 299-325, 1993 | 34 | 1993 |
| 1999 Targeting kinases in CML CLL V Gandhi, LH Sehn, TE Warkentin, JAM Anderson, JN George, HB Feys, ... | | |
| 2: A distinct pattern of Non-HLA polymorphisms predicts an increased risk for GvHD without benefit of GvL in HLA matched sibling transplants for chronic myeloid leukemia (CML) AM Dickinson, KF Pearce, J Norden, A Neylor, E Holler, V Rocha, ... Biology of Blood and Marrow Transplantation 13 (2), 1, 2007 | 3 | 2007 |
| 2009 Pandemic Influenza A H1N1 Vaccination In the Patients with Hematologic Malignancies: Requirement for Repeated Dosing to Optimize Seroprotection H de Lavallade, PL Garland, T Sekine, K Hoschler, D Marin, K Stringaris, ... Blood 116 (21), 677, 2010 | | 2010 |
| 25-35 year outcomes of allogeneic stem cell transplantation for haematological malignancies: a single centre experience A Khoder, R Szydlo, J Apperley, J Todd, N Salooja BONE MARROW TRANSPLANTATION 50, S89-S89, 2015 | | 2015 |
| 2522 autotransplants in multiple myeloma-A registry study from the European group for blood and marrow transplantation (EBMT). B Bjorkstrand, K Svensson, P Ljungman, J Apperley, H Goldschmidt, ... Blood 90 (10), 1862-1862, 1997 | 42 | 1997 |
| 28: A multicenter prospective randomized Phase II study in patients with corticosteroid-refractory/dependent/intolerant chronic cutaneous GVHD given either extracorporeal … HT Greinix, K Van Besien, J Apperley, A Bacigalupo, A Elmaagacli, ... Biology of Blood and Marrow Transplantation 13 (2), 13, 2007 | | 2007 |
| 301 The impact of tailored delivery of education on engagement and disease severity: A randomized controlled trial among adults with psoriasis C Read, JF Apperley, SP Hettiaratchy, SP Pourali, ME Jones, ... Journal of Investigative Dermatology 142 (8), S51, 2022 | | 2022 |
| 33: Increased CD4+ CD25high+ regulatory T-cell are associated with disease relapse after allogeneic stem cell transplantation (SCT) for chronic myeloid leukaemia (CML) E Nadal, J Kaeda, JF Apperley, R Lechler, F Dazzi Biology of Blood and Marrow Transplantation 13 (2), 15, 2007 | | 2007 |
| 34-Year Single Center Observational Review of Ex-Vivo T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplants for Chronic Myeloid Leukemia P Woolley, D Slade, R Syzdlo, GN Nesr, S Claudiani, I Caballes, ... Blood 132, 5746, 2018 | | 2018 |
| 4-Year results from the pivotal phase 2 PACE trial: efficacy and safety in heavily pretreated leukemia patients J Cortes, J Pinilla-Ibarz, P le Coutre, R Paquette, C Chuah, F Nicolini, ... Clinical Lymphoma, Myeloma and Leukemia 16, S56, 2016 | 2 | 2016 |
| 4-year results of the ponatinib phase II PACE trial in patients (pts) with heavily pretreated leukemia. JE Cortes, J Pinilla-Ibarz, PD Le Coutre, R Paquette, C Chuah, FE Nicolini, ... Journal of Clinical Oncology 34 (15_suppl), 7013-7013, 2016 | 7 | 2016 |
| 43rd Advances in Haematology J Apperley, N Cooper, C Millar | | |
| 450 The impact of mental health comorbidities on patient satisfaction: A population study among US adults with skin cancer C Read, JF Apperley, SP Hettiaratchy, A Armstrong Journal of Investigative Dermatology 143 (5), S77, 2023 | | 2023 |
